Navigation Links
Double drug combo could shut down abnormal blood vessel growth that feeds disease
Date:9/10/2012

tential for treating these eye diseases would be if S1P1 axis was also targeted," Dr. Hla says.

In rheumatoid arthritis, which is driven by reactive and inflammatory immune cells, a S1P1 inhibitor could block both immune and blood vessel-related mechanisms, and therefore may be beneficial, based on the study's findings. In addition, Dr. Hla points out that while the existing approved S1P1 inhibitor fingolimod has had some adverse effects in some multiple sclerosis patients, there are new inhibitors of S1P1 being developed by many companies that could also be tested in combination with a VEGF inhibitor for treating these diseases.

An Antenna that Senses Blood Flow

Angiogenesis is needed for many normal tissue growth, repair and regenerative processes, which ultimately results in increased blood flow and oxygenation of tissues.

The Hla laboratory has long been interested in defining the molecular mechanisms of the angiogenic process, in which endothelial cells from pre-existing blood vessels sprout, move and then change to form new vascular channels. Dr. Hla was first to identify S1P1 as a key angiogenic response gene, and he also successfully cloned and characterized the receptor.

In this study, the research team shows that as new blood vessel networks form, the resulting blood flow activates S1P1 on the surface of endothelial cells and relays signals inside these cells to stabilize new blood vessel networks.

"The S1P1 molecule acts like an antenna to sense blood flow. If blood flow is reduced, then normal S1P1 signaling is interrupted, destabilizing blood vessel formation, causing the endothelium to undergo an inflammatory process," Dr. Hla says. "This happens in many diseases with abnormal vessels, including rheumatoid arthritis, psoriasis and even cancer."

In their laboratory studies, the researchers found that blocking S1P1 resulted in abnormal endothelial function and blood vessel growth. In
'/>"/>

Contact: Lauren Woods
law2014@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Obesitys Health Costs Double Earlier Estimates
2. Study finds number of battery-related emergency department visits by children more than doubles
3. Common acne medication doubles risk of eye infection
4. As Obesity Rates Rise, Cases of Kidney Stones Double: Study
5. Osteoarthritis risk not diminished in double bundle ACL surgeries
6. Moms Pot Use Doubles Risk of Preemie Birth: Study
7. Snacking and BMI linked to double effect of brain activity and self-control
8. MRSA cases in academic hospitals double in 5 years: study
9. Adding bavituximab to second-line chemotherapy doubles response rate
10. Experimental Chemo Combo for Colon Cancer Disappoints
11. Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... On a Saturday morning last summer, MSgt. Joe DesLauriers ... Bourne Legacy” at the White Flint Mall movie theater in ... activity to many couples, it is a pure luxury for ... everyday reality has become possible through the Military Family Respite ... , Life changed for the DesLauriers family on Sept. 23, ...
(Date:5/22/2013)... York, New York (PRWEB) May 22, 2013 ... the nation’s first trial involving a da Vinci lawsuit, ... the case, the family of a man who allegedly died ... seeking more than $8 million in damages from Intuitive Surgical, ... down its physician training program for the da Vinci Surgical ...
(Date:5/22/2013)... Nearly 50,000 veterans appeals were received ... year 2012, with even more—54,033—expected by fiscal year-end 2013. ... decision as the agency reports reduced decisions and a ... disability appeal services. The BVA is an agency ... the BVA received 49,611 cases in FY 2012, it ...
(Date:5/22/2013)... CORVALLIS, Ore. A new study shows there is ... self-control in American young children one that does ... In the United States, girls had higher levels of ... to control their behavior and impulses, follow directions, and ... academic performance and college completion, in past studies by ...
(Date:5/22/2013)... May 22, 2013 Successful Therapy ... Patricia O’Laughlin Psychotherapy in the Silver Lake community ... all ages as progression to existing Parents and ... ages into parenting therapy has always been suggested, ... O’Laughlin Psychotherapy now specializes in all aspects of ...
Breaking Medicine News(10 mins):Health News:Military Family Finds Respite with Easter Seals 2Health News:Military Family Finds Respite with Easter Seals 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 2Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 4Health News:Veterans Disability Appeals See Fewer Decisions in FY2012, Reports Allsup 2Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children 2
... 28, 2008 -- WASHINGTON, DC) The American ... Foundation (CRF) announced today a multi-year partnership to ... in Orlando, Fla., March 2831, 2009, during ACC.09, ... worlds premier cardiovascular meeting. This will be ...
... Wins First Canadian Golf Tour Title While Wearing Surgex(TM) Branded ... ... virus and a late bogey to capture his first Canadian Tour title,at the ... victory places the former University of Texas standout in prime,position to qualify for ...
... acid molecules fabricated in the laboratory have been shown ... 1 diabetes in animal models. The results of these ... G. Rangos Sr. Research Center at Childrens Hospital of ... a research study at Childrens Hospital, the scientists injected ...
... ("DRAXIS"),(TSX: DAX) (NASDAQ: DRAX ) announced today the ... common shares have been acquired by,an indirect wholly-owned subsidiary ... a result, DRAXIS common stock is expected to cease,trading ... Stock Exchange at,market close on Thursday, May 29, 2008, ...
... in the May 28, 2008 edition of The Journal ... action of certain brain cells altered by chronic alcohol ... the central amygdala, which plays an important role in ... alcohol drinking. In the study, alcohol-dependent rodents receiving gabapentin ...
... being,issued by the National Academy of Social Insurance:, ... 3:30 pm Seminar: Growing Risks for Workers and Growing ... from Behavioral Economics to Control Health Costs, Peter ... Benefits, Stephen C. Goss, Chief Actuary of the ...
Cached Medicine News:Health News:ACC and CRF announce partnership on ACC's Innovation in Intervention: i2 Summit 2Health News:Surgex(TM) Fuels 2008 San Luis Potosi Open Champion Russell Surber Through Grueling 36 Hole Final Day 2Health News:Surgex(TM) Fuels 2008 San Luis Potosi Open Champion Russell Surber Through Grueling 36 Hole Final Day 3Health News:New vaccine approach prevents/reverses diabetes in lab study at Children's Hospital of Pittsburgh 2Health News:New vaccine approach prevents/reverses diabetes in lab study at Children's Hospital of Pittsburgh 3Health News:DRAXIS Announces Completion of Sale to Jubilant 2Health News:DRAXIS Announces Completion of Sale to Jubilant 3Health News:DRAXIS Announces Completion of Sale to Jubilant 4Health News:Scripps Research scientists find seizure drug reverses cellular effects 2
(Date:5/22/2013)... 2013 Attorney Advertising -- Bronstein, Gewirtz & ... of purchasers of the securities of AMAG Pharmaceuticals, ... The investigation focuses on whether the Company and ... On May 22, 2013, Shares of AMAG dropped ... company announced in regulatory filing that it has ...
(Date:5/22/2013)... and MUNICH , May 22, 2013 /PRNewswire/ ... marketer of transcatheter aortic valve implantation (TAVI) systems for the ... results of the J enaValve Eval U ation of ... Pa T ients with S E vere Ao R tic ... . JUPITER is a post-market registry to evaluate five-year long ...
(Date:5/22/2013)... May 22, 2013 The new 13-valent pneumococcal ... the previous version used prior to 2010, the 7-valent ... study published today in Vaccine. The U.S. ... in 2010 after a series of trials. These trials ... of pneumococcal types than the previously used PCV7, did ...
Breaking Medicine Technology:Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4
... Progen,Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) today announced ... PI-88 as an adjuvant,treatment for primary liver cancer ... patient having been randomized,onto the study. The study ... treatment of HCC). The first patient to enter ...
... SILVER SPRING, Md., March 11 In a boost ... to provide a,royalty-free license to the non-profit International Partnership ... use as a,potential vaginal microbicide., The compound, called ... known as gp41 fusion inhibitors, which inhibit HIV infection ...
Cached Medicine Technology:Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer 2Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer 3Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer 4Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 2Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 3
Used where access is required into superior meniscal flap region....
This family of punches offers the best of both worlds the lowest profile and the largest bite, facilitating end-on and lateral cutting the most versatile instrument available....
The narrow shaft and compact jaw design facilitates access and use in tight spaces, particularly useful in the posterior aspect of the knee....
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
Medicine Products: